Atraumatic prosthetic heart valve prosthesis

Information

  • Patent Grant
  • 8840661
  • Patent Number
    8,840,661
  • Date Filed
    Wednesday, May 13, 2009
    15 years ago
  • Date Issued
    Tuesday, September 23, 2014
    10 years ago
Abstract
An atraumatic heart valve prosthesis includes a prosthetic valve coupled to an expandable anchoring structure including a outflow portion configured to taper inwardly in a distal direction towards a central axis of the prosthesis. By this configuration, the distal end of the anchoring structure imparts less force upon the vessel wall (e.g., the aortic tunica intima) during continued expansion and contraction of the heart. The expandable anchoring structure can be balloon expandable or self-expanding.
Description
TECHNICAL FIELD

The present invention relates to cardiac-valve prostheses. More specifically, the present invention is directed to a prosthesis amenable to a minimally-invasive implantation procedure having a stent-like anchoring structure.


BACKGROUND

The aorta is made up of three layers. The layer that is in direct contact with the flow of blood is the tunica intima, commonly called the intima. This layer is made up of mainly endothelial cells. The next layer is the tunica media, known as the media. This “middle layer” is made up of smooth muscle cells and elastic tissue. The outermost layer (furthest from the flow of blood) is known as the tunica adventitia or the adventitia. This layer is composed of connective tissue.


Expandable heart valve prosthesis are sometimes ballooned or otherwise expanded upon insertion. The ballooning process presses the self-expanding or balloon-expandable portions of the heart valve prosthesis against the Valsalva sinus, higher up in the ascending aorta, and/or lower down into the valve annulus in order to properly anchor the prosthesis. In some instances, the ballooning process may weaken the tunica intima, tunica media and/or tunica adventitia. Additionally, as a result of the expansion and contraction of the heart and movement of the prosthesis over time, the prosthesis may rub against the layers or the aorta and may tear the tunica intima, the tunica media and/or the tunica adventitia, resulting in an aortic dissection. Other factors such as a patient's age or natural predisposition to aortic tears may contribute to an event leading to an aortic dissection and/or aortic rupture.


SUMMARY

According to various embodiments, the present invention is a heart valve prosthesis including a prosthetic heart valve coupled to a balloon expandable anchoring support structure including a outflow portion (e.g., outflow ring) configured to as not to weaken an aortic wall when the prosthesis including the anchoring support structure is transitioned from a collapsed position to an expanded position by inflation of a balloon located within the prosthesis.


According to various other embodiments, the present invention is a heart valve prosthesis configured to facilitate the flow of blood through a heart valve. The heart valve prosthesis is configured to be delivered to an implantation site in a minimally invasive manner, and includes an expandable anchoring support structure having an outflow portion including a distal end, the outflow portion configured to curve inward towards a central axis of the prosthesis such that the distal end of the anchoring support structure is curved away from the implantation site.


According to some embodiments, the anchoring support structure can be balloon expandable. According to other embodiments, the anchoring support structure can be self-expanding. In some embodiments the outflow portion can be smooth and free from rough edges. In yet other embodiments, an outer surface of the outflow portion can be provided with a lubricious coating.


According to other embodiments, the present invention is a system for delivering and implanting a heart valve prosthesis to an implantation site within a patient's heart. In various embodiments the system includes an implantation catheter and a heart valve prosthesis removably mounted onto the implantation catheter. The heart valve prosthesis includes an expandable prosthetic valve coupled to an anchoring support structure including a outflow portion configured to curve inward in a distal direction towards a central axis of the prosthesis such that the distal end of the anchoring support structure is curved away from the implantation site so as not to weaken an aortic tunica intima after continued expansion and contraction of said heart muscle and movement of the outflow portion against the aortic tunica intima. In other embodiments, the system includes an inflatable balloon adapted to expand the heart valve prosthesis at the implantation site in the patient's heart.


While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a cross-sectional view of an aorta of a human heart with an expandable heart valve prosthesis according to an embodiment of the present invention implanted within or adjacent to an aortic valve.



FIGS. 2A and 2B are perspective views of a heart valve prosthesis according to some embodiments of the present invention.



FIG. 3 is a perspective view of a heart valve prosthesis according to another embodiment of the present invention.



FIGS. 4A and 4B are perspectives view of a heart valve prosthesis according to other embodiments of the present invention.





While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.


DETAILED DESCRIPTION


FIG. 1 is a schematic view of an expandable heart valve prosthesis 10 implanted within or adjacent an aortic annulus 16 of an ascending aorta 6. As shown in FIG. 1, the ascending aorta is coupled to the left ventricle 18. During normal operation, the left ventricle 18 pumps blood out of the heart through the aortic annulus 16 and into the ascending aorta 6 (as indicated by the arrows in FIG. 1).


As further shown in FIG. 1, the expandable heart valve prosthesis 10 includes an expandable anchoring or support structure 24 coupled to a prosthetic valve 30. According to various embodiments of the present invention, the heart valve prosthesis 10 is suitable for implantation within or adjacent a valved intraluminal site using endovascular delivery techniques known to those of skill in the art. Exemplary valved intraluminal site includes the aortic valve 16 (as shown in FIG. 1), the tricuspid valve, the pulmonary valve, and the mitral valve annuluses of a patient's heart. As shown in FIG. 1, the heart valve prosthesis 10 can be implanted such that the annular elements 32a and 32b of the anchoring support structure 24 occupy positions proximal and distal, respectively, of the Valsalva sinuses VS, with the flared proximal end of the annular member 32a forming the proximal entrance of the lumen defined by the anchoring support structure 24 of the prosthesis 10.


According to various embodiments of the present invention, as shown in FIG. 1, the heart valve prosthesis 10 includes an anchoring support structure 24 coupled to an prosthetic valve 30, many examples of which are known in the art. According to various embodiments of the present invention, the prosthetic valve 30 can be configured to be implanted within a fluid passageway of a body lumen to regulate the flow of a bodily fluid therethrough in a single direction. Exemplary lumens include cardiac, arterial, or venus valves. In some embodiments, the prosthetic valve 30 is configured to be implanted within or adjacent to the aortic valve. The prosthetic valve 30 is constructed from biocompatible materials so as to minimize any adverse body reaction to the implantation of prosthetic valve 30 at the selected implantation site. In various embodiments, the prosthetic heart valve 30 includes a plurality of valve leaflets 34. In some embodiments, as shown in FIG. 1, the prosthetic valve 30 includes three valve leaflets 34. In other embodiments, the prosthetic valve 30 may include as many as six valve leaflets. The valve leaflets 34 are deflectable between a closed configuration (shown in FIG. 1), in which fluid flow through the valve passageway is restricted, and an open configuration in which fluid flow through the valve passageway is permitted. In some embodiments, the valve leaflets 34 are biased towards a closed, flow-restricting configuration. Exemplary prosthetic heart valves are shown and described in U.S. Publication 2006/0178740 and U.S. Publication 2005/0197695, both of which are incorporated herein by reference.



FIGS. 2A-4B are perspective views of anchoring or support structures 100, 200, 300, and 400 according to various embodiments of the present invention. The anchoring or support structures 100, 200, 300, and 400 have a stent-like configuration and are adapted to support a prosthetic heart valve. The anchoring structures 100, 200, 300, and 400 are adapted to expand from a collapsed or compressed configuration to an expanded configuration. Upon expansion, the anchoring structures 100, 200, 300, and 400 are constrained by the inner vessel wall at the implantation site. The expanded anchoring structures 100, 200, 300, and 400 place sufficient radial expansion force on the inner surface of the implantation site so as to secure and stabilize the anchoring structures 100, 200, 300, and 400 at the implantation site.


According to various embodiments, the anchoring structures 100, 200, 300, and 400 can be balloon expandable or self-expanding. In some embodiments, at least a portion of the anchoring structures 100, 200, 300, and 400 can be expanded using an inflatable balloon. The ballooning process presses the expandable portions of the anchoring structures 100, 200, 300, and 400 against the Valsalva sinus, higher up in the ascending aorta, and/or lower down into the valve annulus in order to properly anchor the prosthesis including the anchoring support structure coupled to an expandable prosthetic valve at the implantation site.


According to various embodiments of the present invention, the anchoring structures 100, 200, 300, and 400 are made from a biocompatible metal or plastic. The anchoring structures 100, 200, 300, and 400 can be formed from a variety of materials including stainless steel, titanium, platinum, gold and other bio-compatible metals. Shape memory plastics, polymers, and thermoplastic materials which are inert in the body may also be employed. According to some embodiments, the anchoring structures 100, 200, 300, and 400 can be formed from Nitinol or other similar shape memory alloys.



FIGS. 2A and 2B are perspective views of anchoring structures 100 and 200 according to exemplary embodiments of the present invention. As shown, the anchoring structures 100 and 200 are adapted to be coupled to an expandable prosthetic heart valve. The anchoring structures 100 and 200 have a stent-like configuration and can be balloon expandable or self-expanding. The anchoring structures 100 and 200 each include an inflow portion 130, 230 and an outflow portion 135, 235 (e.g., an outflow ring). The inflow portions 130, 230 are sized and shaped to be positioned within and secured adjacent to a native valve annulus.


The outflow portions 135, 235 are located distal to an outflow end of an expandable prosthetic heart valve. In some embodiments, the outflow portions 135, 235 are configured to expand within the Valsalva sinuses bearing against the sinus walls when in an expanded configuration. According to other embodiments, the outflow portions 135, 235 are configured to expand higher up within the ascending aorta (i.e., distal to the Valsalva sinuses). In some embodiments, as shown in FIG. 2A, the outflow portion 135 of the anchoring structure 100 is configured such that it has a neck-down portion 140 located between a distal end 160 and a main portion 145. In other embodiments, as shown in FIG. 2B, the outflow portion 235 is configured such that it curves inwardly towards the central axis X1 of the anchoring structure 200. This narrowing or tapering configuration of the outflow portions 135 and 235 will function to minimize trauma to the vessel wall (e.g., the aortic tunica intima) as a result of continued expansion and contraction of the heart and movement of the outflow portions 135, 235 against the vessel wall.



FIG. 3 is a perspective view of an expandable anchoring structure 300 according to other embodiments of the present invention. As shown in FIG. 3, the inflow portion 330 can be flared in an outward direction away from a central axis X1 of the anchoring structure 300. The flared inflow portion 330 is expanded at a position slightly proximal to the valve annulus and facilitates anchorage of the prosthesis at the implantation site. The outflow portion 335 extends distally from an outflow end an expandable prosthetic heart valve coupled to the anchoring structure 300. The outflow portion 335 has a bulbous configuration that is adapted to radially expand and conform the walls of the aorta further securing and stabilizing the support structure 300 and any valve to which it is coupled at the implantation site. Additionally, the outflow portion 335 curves away from the point of contact at the implantation site and towards the central axis of the anchoring structure 300, such that a distal end 360 has a reduced diameter, which minimized the force against the vessel wall (e.g., the aortic tunica intima) during the continued motion caused by the beating of the heart.



FIGS. 4A and 4B are perspective views of an anchoring structure 400 coupled to a prosthetic heart valve 410. According to some embodiments, as shown in FIGS. 4A and 4B, the anchoring structure 400 includes one or more anchoring appendages 450 configured to anchor and stabilize the anchoring structure 400 at the implantation site. One such exemplary anchoring structure is shown and described in co-pending and co-owned U.S. Patent Publication No. 2006/0178740 entitled “Cardiac-Valve Prosthesis,” filed Feb. 10, 2006, which is herein incorporated by reference in its entirety. The anchoring appendages 450 are sized and shaped to project into the Valsalva sinuses when the anchoring structure is in its expanded configuration. The outflow portion 435 has a stent-like configuration and is adapted to contact the vessel wall at a location distal to the Valsalva sinus. As shown, the outflow portion 435 is curved inwardly from the vessel wall towards the central axis X1 of the anchoring structure 400.


According to one embodiment, the outflow portion 435 includes two outflow rings 460 and 465 coupled together. The proximal outflow ring 460 is disposed proximal to the distal outflow ring 465. As shown in FIGS. 4A and 4B, the proximal outflow ring 465 extends generally parallel to a longitudinal axis of the support structure 400. The distal outflow ring 460, on the other hand, narrows in diameter in a distal direction. According to some embodiments, the distal outflow ring 460 extends generally linearly from the distal end of the proximal outflow ring 465 to a distal end location having a reduced diameter. According to other embodiments, the distal outflow ring 460 extends along a curved, concave (from the perspective of the longitudinal axis) path in a distal direction. According to one embodiment, the distal end of distal outflow ring 460 is disposed between about 0.5 and about 3 mm closer to the longitudinal axis than is the distal end of the proximal outflow ring 465.


In various exemplary embodiments, the distal outflow ring 460 tapers inwardly, in a generally linear fashion, at an angle of between about 5 and about 40 degrees with respect to the central axis X1. In some embodiments of the invention, the distal outflow ring 460 tapers inwardly, in a generally linear fashion, at an angle of between about 15 and about 25 degrees. In yet other embodiments, the distal outflow ring 460 tapers inwardly, in a generally linear fashion, at an angle of about 20 degrees. In various embodiment of the invention, the proximal outflow ring 465 and distal outflow ring 460 have generally the same length of between about 2 and about 5 mm each. In one exemplary embodiment, the proximal outflow ring 465 and distal outflow ring 460 have a combined length of about 7 mm.


According to various embodiments of the present invention, the inflow portions of the anchoring structures described above may include a suture ring adapted to further anchor and secure the prostheses at the implantation site. According to yet other embodiments, the prosthetic valves coupled to the anchoring structures may include a cuff, skirt, or other sealing means at the base of the expandable valve so as to provide an efficient seal between the prosthesis and the implantation site preventing the leakage of fluid at the implantation site.


According to various embodiments of the present invention, the outer surface of the anchoring structure is smooth and free from rough edges. In some embodiments, the distal ends 160, 260, 360, and 460 of the outflow portions 134, 235, 335, and 435 of the anchoring structures 100, 200, 300, and 400 are blunt or free from sharp edges so as to reduce the risk of snagging or tearing the vessel wall at the implantation site. According to other embodiments, the outflow portions 135, 235, 335, and 435 may include a lubricious coating. In some embodiments, a lubricious coating may be applied to the outer surface of the entire anchoring support structure 100, 200, 300, and 400. An exemplary lubricious coating is Teflon. Other lubricious coatings known to those of skill in the art may also be applied to the outer surface of the outflow portions 135, 235, 335, and 435 of the anchoring structures 100, 200, 300, and 400. According to another embodiment, the outflow portions 135, 235, 335, and 435 are covered with a protective material to prevent trauma to or tearing of the aortic tunica intima.


According to some embodiments, outflow portions 135, 235, 335, and 435 are shaped to decrease the shearing of blood cells passing over or through the low portion and may decrease blood flow turbulence through the prosthesis.


The heart valve prosthesis 10 of the present invention can be delivered to the implantation site using any of a variety of techniques known in the art. For example, it may be delivered through a delivery catheter using techniques and tools known to those of skill in the art. In some embodiments, a crimping tool or other similar device known to those of skill in the art can be used to radially collapse the prosthetic heart valve including the anchoring structure. After the prosthesis has been transitioned from an expanded position to a collapsed position, the prosthesis can be loaded into a delivery catheter. The prosthesis can then be delivered to a target implantation site within a patient's heart using known methods and techniques in a minimally invasive manner. According to some embodiments, the delivery catheter is then withdrawn facilitating the automatic expansion of the prosthesis including the support structure from its collapsed configuration to its expanded configuration.


According to other embodiments, an inflatable balloon can be inserted and expanded within the prosthetic heart valve facilitating expansion of the valve and the support structure at the implantation site. According to various embodiments, the expandable stent structure is sized and shaped to prevent a locus minoris resistentiae in an aortic wall when the prosthesis is balloon expanded.


Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.

Claims
  • 1. A heart valve prosthesis adapted for minimally invasive delivery to an implantation site of a patient, the implantation site having an annulus, Valsalva sinuses, and an aortic tunica intima, the prosthesis having a principal axis extending longitudinally therethrough and comprising: an anchoring structure having a radially collapsed configuration for delivery and a radially expanded configuration for deployment;a valve coupled to the anchoring structure and configured such that in the expanded configuration, the valve permits blood flow through the lumen in a first direction and substantially prevents blood flow through the lumen in a second direction generally opposite the first direction;wherein the anchoring structure includes a generally cylindrical portion adapted to engage an annular vessel wall at the implantation site;wherein the generally cylindrical portion includes an outflow portion adapted to engage the vessel wall at a location distal to the Valsalva sinuses, an inflow portion that is sized and shaped to be positioned within and secured adjacent the annulus, and a plurality of anchoring members, angularly spaced from one another about the principal axis, extending between the outflow portion and the inflow portion, wherein the anchoring members are angularly distributed in three pairs, and only three pairs, around the prosthesis at an angular distance apart of about 120° about the principal axis, such as to be configured to extend into the sinuses of Valsalva;further wherein, in the radially expanded configuration, each of the plurality of anchoring members arches radially outward from the principal axis; andwherein, in the expanded configuration, the outflow portion includes a proximal outflow ring having a first distal end having a first diameter and a distal outflow ring having a second distal end having a second diameter, the second diameter being smaller than the first diameter, such that the distal end tapers inwardly and thus imparts less force than a proximal portion upon the aortic tunica intima, wherein the proximal outflow ring is disposed proximal to the distal outflow ring, and wherein the first distal end of the proximal outflow ring and the second distal end of the distal outflow ring are coupled together by the anchoring members.
  • 2. The prosthesis of claim 1 wherein the implantation site is the aortic annulus of the patient.
  • 3. The prosthesis of claim 1 wherein the distal outflow ring defines a concave curved configuration.
  • 4. The prosthesis of claim 3 further comprising a prosthetic heart valve including three coapting leaflets, the valve coupled to the anchoring support structure.
  • 5. The prosthesis of claim 1 wherein the anchoring structure is configured to be self-expanding.
  • 6. The prosthesis of claim 1 further wherein the second distal end of the distal outflow ring has a smaller diameter than a proximal end of the distal outflow ring and wherein the second distal end of the distal outflow ring is disposed between about 0.5 and about 3 mm closer to a longitudinal axis of the anchoring structure than is the first distal end of the proximal outflow ring.
  • 7. A heart valve prosthesis configured for delivery to an implantation site in a minimally invasive manner, the prosthesis having a principal axis extending longitudinally therethrough and comprising an expandable anchoring structure having a tapered outflow portion adapted to engage a vessel wall at a location distal to Valsalva sinuses, an inflow portion that is sized and shaped to be positioned within and secured adjacent a valve annulus, and a plurality of anchoring members extending between the outflow portion and the inflow portion and angularly spaced about the principal axis, wherein the anchoring members are angularly distributed in three pairs, and only three pairs, around the prosthesis at an angular distance apart of about 120° about the principal axis, so as to allow the anchoring members to extend into the sinuses of Valsalva, and wherein each of the plurality of anchoring members arches radially outward from the principal axis, the outflow portion including a proximal outflow ring having a first distal end having a first diameter and a distal outflow ring having a second distal end having a second diameter, the second diameter being smaller than the first diameter, so as to minimize damage to an aortic tunica intima, and wherein the first distal end of the proximal outflow ring and the second distal end of the distal outflow ring are coupled together by the anchoring members.
  • 8. The heart valve prosthesis of claim 7 further comprising an expandable prosthetic heart valve including three leaflets coupled to the anchoring support structure.
  • 9. The heart valve prosthesis of claim 7 wherein the anchoring structure is a stented structure and the outflow portion is curved away from the aortic tunica intima.
  • 10. The heart valve prosthesis of claim 7 wherein the outflow portion is blunt.
  • 11. The heart valve prosthesis according to claim 10 wherein the distal end is configured so as not to snag tissue at the implantation site.
  • 12. The heart valve prosthesis of claim 7 wherein the outflow portion is covered with a protective coating or material.
  • 13. The heart valve prosthesis according to claim 7 wherein the outflow portion is dimensioned to minimize shearing of blood cells passing by the outflow portion.
  • 14. The heart valve prosthesis according to claim 7 wherein the outflow portion is configured to minimize blood flow turbulence through the prosthesis.
  • 15. The heart valve prosthesis of claim 7 wherein an outside surface of the outflow portion is smooth and free from rough edges.
  • 16. The heart valve prosthesis of claim 7 wherein the outside surface of the anchoring support structure includes a lubricious coating.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims the benefit of Provisional Application No. 61/053,943, filed May 16, 2008, which is herein incorporated by reference in its entirety.

US Referenced Citations (777)
Number Name Date Kind
3143742 Cromie Aug 1964 A
3334629 Cohn Aug 1967 A
3409013 Berry Nov 1968 A
3540431 Kazi Nov 1970 A
3546710 Ivanovich et al. Dec 1970 A
3574865 Hamaker Apr 1971 A
3587115 Shiley Jun 1971 A
3608097 Bellhouse et al. Sep 1971 A
3628535 Ostrowsky et al. Dec 1971 A
3642004 Osthagen et al. Feb 1972 A
3657744 Ersek Apr 1972 A
3671979 Moulopoulos Jun 1972 A
3744060 Bellhouse et al. Jul 1973 A
3755823 Hancock Sep 1973 A
3795246 Sturgeon Mar 1974 A
3839741 Haller Oct 1974 A
3868956 Alfidi et al. Mar 1975 A
3874388 King et al. Apr 1975 A
3997923 Possis Dec 1976 A
4035849 Angell et al. Jul 1977 A
4056854 Boretos et al. Nov 1977 A
4086665 Poirier May 1978 A
4106129 Carpentier et al. Aug 1978 A
4222126 Boretos et al. Sep 1980 A
4233690 Akins Nov 1980 A
4265694 Boretos et al. May 1981 A
4291420 Reul Sep 1981 A
4297749 Davis et al. Nov 1981 A
4339831 Johnson Jul 1982 A
4343048 Ross et al. Aug 1982 A
4345340 Rosen Aug 1982 A
4425908 Simon Jan 1984 A
4451936 Carpentier et al. Jun 1984 A
4470157 Love Sep 1984 A
4477930 Totten et al. Oct 1984 A
4501030 Lane Feb 1985 A
4506394 Bedard Mar 1985 A
4574803 Storz Mar 1986 A
4580568 Gianturco Apr 1986 A
4592340 Boyles Jun 1986 A
4610688 Silvestrini et al. Sep 1986 A
4612011 Kautzky Sep 1986 A
4624822 Arru et al. Nov 1986 A
4647283 Carpentier et al. Mar 1987 A
4648881 Carpentier et al. Mar 1987 A
4655218 Kulik et al. Apr 1987 A
4655771 Wallsten Apr 1987 A
4662885 DiPisa, Jr. May 1987 A
4665906 Jervis May 1987 A
4681908 Broderick et al. Jul 1987 A
4692164 Dzemeshkevich et al. Sep 1987 A
4710192 Liotta et al. Dec 1987 A
4733665 Palmaz Mar 1988 A
4758151 Arru et al. Jul 1988 A
4777951 Cribier et al. Oct 1988 A
4787899 Lazarus Nov 1988 A
4796629 Grayzel Jan 1989 A
4797901 Goerne et al. Jan 1989 A
4819751 Shimada et al. Apr 1989 A
4834755 Silvestrini et al. May 1989 A
4856516 Hillstead Aug 1989 A
4872874 Taheri Oct 1989 A
4878495 Grayzel Nov 1989 A
4878906 Lindemann et al. Nov 1989 A
4883458 Shiber Nov 1989 A
4909252 Goldberger Mar 1990 A
4917102 Miller et al. Apr 1990 A
4922905 Strecker May 1990 A
4954126 Wallsten Sep 1990 A
4966604 Reiss Oct 1990 A
4979939 Shiber Dec 1990 A
4986830 Owens et al. Jan 1991 A
4994077 Dobben Feb 1991 A
5002559 Tower Mar 1991 A
5007896 Shiber Apr 1991 A
5026366 Leckrone Jun 1991 A
5032128 Alonso Jul 1991 A
5037434 Lane Aug 1991 A
5047041 Samuels Sep 1991 A
5059177 Towne et al. Oct 1991 A
5061273 Yock Oct 1991 A
5084151 Vallana et al. Jan 1992 A
5085635 Cragg Feb 1992 A
5089015 Ross Feb 1992 A
5123919 Sauter et al. Jun 1992 A
5133845 Vallana et al. Jul 1992 A
5139515 Robicsek Aug 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5161547 Tower Nov 1992 A
5163953 Vince Nov 1992 A
5163954 Curcio et al. Nov 1992 A
5167628 Boyles Dec 1992 A
5217483 Tower Jun 1993 A
5232445 Bonzel Aug 1993 A
5272909 Nguyen et al. Dec 1993 A
5295958 Shturman Mar 1994 A
5300086 Gory et al. Apr 1994 A
5314468 Ramos Martinez May 1994 A
5327774 Nguyen et al. Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5350398 Pavcnik et al. Sep 1994 A
5370684 Vallana et al. Dec 1994 A
5370685 Stevens Dec 1994 A
5387247 Vallana et al. Feb 1995 A
5389106 Tower Feb 1995 A
5397351 Pavcnik et al. Mar 1995 A
5411552 Andersen et al. May 1995 A
5415633 Lazarus et al. May 1995 A
5423886 Arru et al. Jun 1995 A
5431676 Dubrul et al. Jul 1995 A
5443446 Shturman Aug 1995 A
5449384 Johnson Sep 1995 A
5480424 Cox Jan 1996 A
5489294 McVenes et al. Feb 1996 A
5489297 Duran Feb 1996 A
5496346 Horzewski et al. Mar 1996 A
5507767 Maeda et al. Apr 1996 A
5545209 Roberts et al. Aug 1996 A
5545211 An et al. Aug 1996 A
5545214 Stevens Aug 1996 A
5545215 Duran Aug 1996 A
5554185 Block et al. Sep 1996 A
5575818 Pinchuk Nov 1996 A
5580922 Park et al. Dec 1996 A
5591195 Taheri et al. Jan 1997 A
5609626 Quijano et al. Mar 1997 A
5645559 Hachtman et al. Jul 1997 A
5665115 Cragg Sep 1997 A
5667523 Bynon et al. Sep 1997 A
5674277 Freitag Oct 1997 A
5695498 Tower Dec 1997 A
5702368 Stevens et al. Dec 1997 A
5712953 Langs Jan 1998 A
5713953 Vallana et al. Feb 1998 A
5716417 Girard et al. Feb 1998 A
5746709 Rom et al. May 1998 A
5749890 Shaknovich May 1998 A
5766151 Valley et al. Jun 1998 A
5782809 Umeno et al. Jul 1998 A
5800456 Maeda et al. Sep 1998 A
5800508 Goicoechea et al. Sep 1998 A
5807405 Vanney et al. Sep 1998 A
5817126 Imran Oct 1998 A
5824037 Fogarty et al. Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5824043 Cottone, Jr. Oct 1998 A
5824053 Khosravi et al. Oct 1998 A
5824056 Rosenberg Oct 1998 A
5824061 Quijano et al. Oct 1998 A
5824064 Taheri Oct 1998 A
5840081 Andersen et al. Nov 1998 A
5843158 Lenker et al. Dec 1998 A
5843244 Pelton et al. Dec 1998 A
5851232 Lois Dec 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5860996 Urban et al. Jan 1999 A
5861028 Angell Jan 1999 A
5868783 Tower Feb 1999 A
5876436 Vanney et al. Mar 1999 A
5876448 Thompson et al. Mar 1999 A
5888201 Stinson et al. Mar 1999 A
5891191 Stinson Apr 1999 A
5891195 Klostermeyer et al. Apr 1999 A
5906619 Olson et al. May 1999 A
5907893 Zadno Azizi et al. Jun 1999 A
5913842 Boyd et al. Jun 1999 A
5925063 Khosravi Jul 1999 A
5944738 Amplatz et al. Aug 1999 A
5954766 Zadno Azizi et al. Sep 1999 A
5957949 Leonhardt et al. Sep 1999 A
5968068 Dehdashtian et al. Oct 1999 A
5980570 Simpson Nov 1999 A
5984957 Laptewicz, Jr. et al. Nov 1999 A
5997573 Quijano et al. Dec 1999 A
6010531 Donlon et al. Jan 2000 A
6019790 Holmberg et al. Feb 2000 A
6022370 Tower Feb 2000 A
6027525 Suh et al. Feb 2000 A
6029671 Stevens et al. Feb 2000 A
6042589 Marianne Mar 2000 A
6042598 Tsugita et al. Mar 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6051104 Oriaran et al. Apr 2000 A
6059809 Amor et al. May 2000 A
6059827 Fenton, Jr. May 2000 A
6110201 Quijano et al. Aug 2000 A
6146366 Schachar Nov 2000 A
6159239 Greenhalgh Dec 2000 A
6162208 Hipps Dec 2000 A
6162245 Jayaraman Dec 2000 A
6168614 Andersen et al. Jan 2001 B1
6171335 Wheatley et al. Jan 2001 B1
6187016 Hedges et al. Feb 2001 B1
6197143 Bodnar Mar 2001 B1
6200336 Pavcnik et al. Mar 2001 B1
6203550 Olson Mar 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6218662 Tchakarov et al. Apr 2001 B1
6221006 Dubrul et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6241757 An et al. Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6248116 Chevillon et al. Jun 2001 B1
6258114 Konya et al. Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6270526 Cox Aug 2001 B1
6277555 Duran et al. Aug 2001 B1
6287339 Vazquez et al. Sep 2001 B1
6299637 Shaolian et al. Oct 2001 B1
6299638 Sauter Oct 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6309382 Garrison et al. Oct 2001 B1
6309417 Spence Oct 2001 B1
6312462 McDermott et al. Nov 2001 B1
6338735 Stevens Jan 2002 B1
6348063 Yassour et al. Feb 2002 B1
6350277 Kocur Feb 2002 B1
6352554 De Paulis Mar 2002 B2
6352708 Duran et al. Mar 2002 B1
6371970 Khosravi et al. Apr 2002 B1
6371983 Lane Apr 2002 B1
6379383 Palmaz et al. Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6398807 Chouinard et al. Jun 2002 B1
6402780 Williamson, IV et al. Jun 2002 B2
6409750 Hyodoh et al. Jun 2002 B1
6424885 Niemeyer et al. Jul 2002 B1
6425916 Garrison et al. Jul 2002 B1
6440164 DiMatteo et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6468303 Amplatz et al. Oct 2002 B1
6475239 Campbell et al. Nov 2002 B1
6482228 Norred Nov 2002 B1
6488704 Connelly et al. Dec 2002 B1
6493608 Niemeyer Dec 2002 B1
6494909 Greenhalgh Dec 2002 B2
6503272 Duerig et al. Jan 2003 B2
6508833 Pavcnik et al. Jan 2003 B2
6527800 McGuckin, Jr. et al. Mar 2003 B1
6530949 Konya et al. Mar 2003 B2
6544285 Thubrikar et al. Apr 2003 B1
6562031 Chandrasekaran et al. May 2003 B2
6562058 Seguin et al. May 2003 B2
6569196 Vesely May 2003 B1
6582462 Andersen et al. Jun 2003 B1
6585758 Chouinard et al. Jul 2003 B1
6592546 Barbut et al. Jul 2003 B1
6605112 Moll et al. Aug 2003 B1
6613077 Gilligan et al. Sep 2003 B2
6622604 Chouinard et al. Sep 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6652571 White et al. Nov 2003 B1
6652578 Bailey et al. Nov 2003 B2
6656213 Solem Dec 2003 B2
6656219 Wiktor Dec 2003 B1
6663663 Kim et al. Dec 2003 B2
6669724 Park et al. Dec 2003 B2
6673089 Yassour et al. Jan 2004 B1
6673109 Cox Jan 2004 B2
6676684 Morley et al. Jan 2004 B1
6676692 Rabkin et al. Jan 2004 B2
6676698 McGuckin, Jr. et al. Jan 2004 B2
6679893 Tran Jan 2004 B1
6682558 Tu et al. Jan 2004 B2
6685739 DiMatteo et al. Feb 2004 B2
6689144 Gerberding Feb 2004 B2
6689164 Seguin Feb 2004 B1
6692512 Jang Feb 2004 B2
6692513 Streeter et al. Feb 2004 B2
6695878 McGuckin, Jr. et al. Feb 2004 B2
6702851 Chinn et al. Mar 2004 B1
6719789 Cox Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6730377 Wang May 2004 B2
6733525 Yang et al. May 2004 B2
6736846 Cox May 2004 B2
6752828 Thornton Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6786925 Schoon et al. Sep 2004 B1
6790229 Berreklouw Sep 2004 B1
6790230 Beyersdorf et al. Sep 2004 B2
6792979 Konya et al. Sep 2004 B2
6797002 Spence et al. Sep 2004 B2
6805711 Quijano et al. Oct 2004 B2
6821297 Snyders Nov 2004 B2
6830575 Stenzel et al. Dec 2004 B2
6830584 Seguin Dec 2004 B1
6830585 Artof et al. Dec 2004 B1
6846325 Liddicoat Jan 2005 B2
6866650 Stevens et al. Mar 2005 B2
6872223 Roberts et al. Mar 2005 B2
6875231 Anduiza et al. Apr 2005 B2
6883522 Spence et al. Apr 2005 B2
6887266 Williams et al. May 2005 B2
6890330 Streeter et al. May 2005 B2
6893460 Spenser et al. May 2005 B2
6896690 Lambrecht et al. May 2005 B1
6908481 Cribier Jun 2005 B2
6913600 Valley et al. Jul 2005 B2
6929653 Strecter Aug 2005 B2
6936066 Palmaz et al. Aug 2005 B2
6939365 Fogarty et al. Sep 2005 B1
6951571 Srivastava Oct 2005 B1
6974474 Pavcnik et al. Dec 2005 B2
6974476 McGuckin, Jr. et al. Dec 2005 B2
6986742 Hart et al. Jan 2006 B2
6989027 Allen et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6991649 Sievers Jan 2006 B2
7018401 Hyodoh et al. Mar 2006 B1
7018404 Holmberg et al. Mar 2006 B2
7018406 Seguin et al. Mar 2006 B2
7041128 McGuckin, Jr. et al. May 2006 B2
7044966 Svanidze et al. May 2006 B2
7048014 Hyodoh et al. May 2006 B2
7097659 Woolfson et al. Aug 2006 B2
7105016 Shiu et al. Sep 2006 B2
7115141 Menz et al. Oct 2006 B2
7125418 Hill Oct 2006 B2
7128759 Osborne et al. Oct 2006 B2
7147663 Berg et al. Dec 2006 B1
7153324 Case et al. Dec 2006 B2
7160319 Chouinard et al. Jan 2007 B2
7175656 Khairkhahan Feb 2007 B2
7186265 Sharkawy et al. Mar 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201761 Woolfson et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7211107 Bruckheimer et al. May 2007 B2
7252682 Seguin Aug 2007 B2
7255706 Rosengart Aug 2007 B2
7261732 Justino Aug 2007 B2
7276078 Spenser et al. Oct 2007 B2
7300457 Palmaz Nov 2007 B2
7300463 Liddicoat Nov 2007 B2
7316706 Bloom et al. Jan 2008 B2
7329278 Seguin et al. Feb 2008 B2
7329279 Haug et al. Feb 2008 B2
7335218 Wilson et al. Feb 2008 B2
7338520 Bailey et al. Mar 2008 B2
7347869 Hojeibane et al. Mar 2008 B2
7351256 Hojeibane et al. Apr 2008 B2
7374571 Pease et al. May 2008 B2
7377938 Sarac et al. May 2008 B2
7377941 Rhee et al. May 2008 B2
7381218 Schreck Jun 2008 B2
7384411 Condado Jun 2008 B1
7393360 Spenser et al. Jul 2008 B2
7429269 Schwammenthal et al. Sep 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
7453227 Prisco et al. Nov 2008 B2
7462191 Spenser et al. Dec 2008 B2
7470284 Lambrecht et al. Dec 2008 B2
7481838 Carpentier et al. Jan 2009 B2
7534259 Lashinski et al. May 2009 B2
7544206 Cohn Jun 2009 B2
7547322 Sarac et al. Jun 2009 B2
7556645 Lashinski et al. Jul 2009 B2
7556646 Yang et al. Jul 2009 B2
7569071 Haverkost et al. Aug 2009 B2
7578843 Shu Aug 2009 B2
7585321 Cribier Sep 2009 B2
7591848 Allen Sep 2009 B2
7618446 Andersen et al. Nov 2009 B2
7618447 Case et al. Nov 2009 B2
7682390 Seguin Mar 2010 B2
7708775 Rowe et al. May 2010 B2
7780726 Seguin Aug 2010 B2
7806919 Bloom et al. Oct 2010 B2
7857845 Stacchino et al. Dec 2010 B2
7972378 Tabor et al. Jul 2011 B2
7981153 Fogarty et al. Jul 2011 B2
8083793 Lane et al. Dec 2011 B2
8109996 Stacchino et al. Feb 2012 B2
8539662 Stacchino et al. Sep 2013 B2
8540768 Stacchino et al. Sep 2013 B2
20010001314 Davison et al. May 2001 A1
20010002445 Vesely May 2001 A1
20010007956 Letac et al. Jul 2001 A1
20010010017 Letac et al. Jul 2001 A1
20010011189 Drasler et al. Aug 2001 A1
20010021872 Bailey et al. Sep 2001 A1
20010025196 Chinn et al. Sep 2001 A1
20010032013 Marton Oct 2001 A1
20010039450 Pavcnik et al. Nov 2001 A1
20010041928 Pavcnik et al. Nov 2001 A1
20010044647 Pinchuk et al. Nov 2001 A1
20020010508 Chobotov Jan 2002 A1
20020029014 Jayaraman Mar 2002 A1
20020029783 Stevens et al. Mar 2002 A1
20020032480 Spence et al. Mar 2002 A1
20020032481 Gabbay Mar 2002 A1
20020035396 Heath Mar 2002 A1
20020042650 Vardi et al. Apr 2002 A1
20020042651 Liddicoat et al. Apr 2002 A1
20020058994 Hill et al. May 2002 A1
20020058995 Stevens May 2002 A1
20020072789 Hackett et al. Jun 2002 A1
20020095209 Zadno Azizi et al. Jul 2002 A1
20020103533 Langberg et al. Aug 2002 A1
20020107565 Greenhalgh Aug 2002 A1
20020111674 Chouinard et al. Aug 2002 A1
20020123802 Snyders Sep 2002 A1
20020128702 Menz et al. Sep 2002 A1
20020133183 Lentz et al. Sep 2002 A1
20020133226 Marquez et al. Sep 2002 A1
20020138138 Yang Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020161377 Rabkin Oct 2002 A1
20020161392 Dubrul Oct 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020183839 Garrison et al. Dec 2002 A1
20020193871 Beyersdorf et al. Dec 2002 A1
20020198594 Schreck Dec 2002 A1
20030014104 Cribier Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030028247 Cali Feb 2003 A1
20030036791 Philipp et al. Feb 2003 A1
20030036795 Andersen et al. Feb 2003 A1
20030040771 Hyodoh et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030050694 Yang et al. Mar 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030065386 Weadock Apr 2003 A1
20030069492 Abrams et al. Apr 2003 A1
20030109924 Cribier Jun 2003 A1
20030125795 Pavcnik et al. Jul 2003 A1
20030130726 Thorpe et al. Jul 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030139804 Hankh et al. Jul 2003 A1
20030149475 Hyodoh et al. Aug 2003 A1
20030149476 Damm et al. Aug 2003 A1
20030149478 Figulla et al. Aug 2003 A1
20030153974 Spenser et al. Aug 2003 A1
20030163194 Quijano et al. Aug 2003 A1
20030181850 Diamond et al. Sep 2003 A1
20030191519 Lombardi et al. Oct 2003 A1
20030191528 Quijano et al. Oct 2003 A1
20030199913 Dubrul et al. Oct 2003 A1
20030199963 Tower et al. Oct 2003 A1
20030208261 Thorpe et al. Nov 2003 A1
20030212410 Stenzel et al. Nov 2003 A1
20030212454 Scott et al. Nov 2003 A1
20030225445 Derus et al. Dec 2003 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040034407 Sherry Feb 2004 A1
20040034411 Quijano et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040049224 Buehlmann et al. Mar 2004 A1
20040049262 Obermiller et al. Mar 2004 A1
20040049266 Anduiza et al. Mar 2004 A1
20040055606 Hendricksen et al. Mar 2004 A1
20040073301 Donlon et al. Apr 2004 A1
20040078072 Tu et al. Apr 2004 A1
20040078074 Anderson et al. Apr 2004 A1
20040082904 Houde et al. Apr 2004 A1
20040088045 Cox May 2004 A1
20040092858 Wilson et al. May 2004 A1
20040092989 Wilson et al. May 2004 A1
20040093005 Durcan May 2004 A1
20040093060 Seguin et al. May 2004 A1
20040093070 Hojeibane et al. May 2004 A1
20040093075 Kuehne May 2004 A1
20040097788 Mourlas et al. May 2004 A1
20040098112 DiMatteo et al. May 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040106990 Spence et al. Jun 2004 A1
20040111096 Tu et al. Jun 2004 A1
20040116951 Rosengart Jun 2004 A1
20040117004 Osborne et al. Jun 2004 A1
20040122468 Yodfat et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040122516 Fogarty et al. Jun 2004 A1
20040127979 Wilson et al. Jul 2004 A1
20040138742 Myers et al. Jul 2004 A1
20040138743 Myers et al. Jul 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040167573 Williamson et al. Aug 2004 A1
20040167620 Ortiz et al. Aug 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040186563 Lobbi Sep 2004 A1
20040193261 Berreklouw Sep 2004 A1
20040210240 Saint Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040215333 Duran et al. Oct 2004 A1
20040215339 Drasler et al. Oct 2004 A1
20040225353 McGuckin et al. Nov 2004 A1
20040225354 Allen et al. Nov 2004 A1
20040225355 Stevens Nov 2004 A1
20040254636 Flagle et al. Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20040267357 Allen et al. Dec 2004 A1
20050010246 Streeter et al. Jan 2005 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050010287 Macoviak et al. Jan 2005 A1
20050015112 Cohn et al. Jan 2005 A1
20050027348 Case et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050049692 Numamoto et al. Mar 2005 A1
20050049696 Siess et al. Mar 2005 A1
20050055088 Liddicoat et al. Mar 2005 A1
20050060029 Le et al. Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075712 Biancucci et al. Apr 2005 A1
20050075713 Biancucci et al. Apr 2005 A1
20050075717 Nguyen et al. Apr 2005 A1
20050075718 Nguyen et al. Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075720 Nguyen et al. Apr 2005 A1
20050075724 Svanidze et al. Apr 2005 A1
20050075726 Svanidze et al. Apr 2005 A1
20050075727 Wheatley Apr 2005 A1
20050075728 Nguyen et al. Apr 2005 A1
20050075729 Nguyen et al. Apr 2005 A1
20050075730 Myers et al. Apr 2005 A1
20050075731 Artof et al. Apr 2005 A1
20050085841 Eversull et al. Apr 2005 A1
20050085842 Eversull et al. Apr 2005 A1
20050085843 Opolski et al. Apr 2005 A1
20050085890 Rasmussen et al. Apr 2005 A1
20050085900 Case et al. Apr 2005 A1
20050096568 Kato May 2005 A1
20050096692 Linder et al. May 2005 A1
20050096724 Stenzel et al. May 2005 A1
20050096734 Majercak et al. May 2005 A1
20050096735 Hojeibane et al. May 2005 A1
20050096736 Osse et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050113910 Paniagua et al. May 2005 A1
20050119688 Bergheim Jun 2005 A1
20050131438 Cohn Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137692 Haug et al. Jun 2005 A1
20050137693 Haug et al. Jun 2005 A1
20050137694 Haug et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050137697 Salahieh et al. Jun 2005 A1
20050137698 Salahieh et al. Jun 2005 A1
20050137699 Salahieh et al. Jun 2005 A1
20050137701 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050143807 Pavcnik et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050148997 Valley et al. Jul 2005 A1
20050149181 Eberhardt Jul 2005 A1
20050165477 Anduiza et al. Jul 2005 A1
20050187616 Realyvasquez Aug 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203605 Dolan Sep 2005 A1
20050203618 Sharkawy et al. Sep 2005 A1
20050222674 Paine Oct 2005 A1
20050222675 Sauter Oct 2005 A1
20050228495 Macoviak Oct 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050240263 Fogarty et al. Oct 2005 A1
20050261759 Lambrecht et al. Nov 2005 A1
20050283962 Boudjemline Dec 2005 A1
20060004439 Spenser et al. Jan 2006 A1
20060004442 Spenser et al. Jan 2006 A1
20060004469 Sokel Jan 2006 A1
20060009841 McGuckin et al. Jan 2006 A1
20060025855 Lashinski et al. Feb 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058775 Stevens et al. Mar 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060085060 Campbell Apr 2006 A1
20060089711 Dolan Apr 2006 A1
20060100685 Seguin et al. May 2006 A1
20060116757 Lashinski et al. Jun 2006 A1
20060135964 Vesely Jun 2006 A1
20060142848 Gabbay Jun 2006 A1
20060167474 Bloom et al. Jul 2006 A1
20060178740 Stacchino et al. Aug 2006 A1
20060190017 Cyr et al. Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060195184 Lane et al. Aug 2006 A1
20060206192 Tower et al. Sep 2006 A1
20060206202 Bonhoeffer et al. Sep 2006 A1
20060212111 Case et al. Sep 2006 A1
20060247763 Slater Nov 2006 A1
20060253134 Ortiz et al. Nov 2006 A1
20060259134 Schwammenthal et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060271166 Thill et al. Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060276874 Wilson et al. Dec 2006 A1
20060276882 Case et al. Dec 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20070005129 Damm et al. Jan 2007 A1
20070005131 Taylor Jan 2007 A1
20070010878 Rafiee et al. Jan 2007 A1
20070016286 Herrmann et al. Jan 2007 A1
20070027518 Case et al. Feb 2007 A1
20070027533 Douk Feb 2007 A1
20070032850 Ruiz et al. Feb 2007 A1
20070038295 Case et al. Feb 2007 A1
20070043431 Melsheimer Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070073387 Forster et al. Mar 2007 A1
20070073392 Heyninck Jantz et al. Mar 2007 A1
20070078509 Lotfy Apr 2007 A1
20070078510 Ryan Apr 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070093869 Bloom et al. Apr 2007 A1
20070093887 Case et al. Apr 2007 A1
20070093890 Eliasen et al. Apr 2007 A1
20070100432 Case et al. May 2007 A1
20070100435 Case et al. May 2007 A1
20070100439 Cangialosi et al. May 2007 A1
20070100440 Figulla et al. May 2007 A1
20070100449 O'Neil et al. May 2007 A1
20070106372 Osborne et al. May 2007 A1
20070112415 Bartlett May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070118209 Strecker May 2007 A1
20070118215 Moaddeb May 2007 A1
20070142968 Prisco et al. Jun 2007 A1
20070162102 Ryan et al. Jul 2007 A1
20070162113 Sharkawy et al. Jul 2007 A1
20070168024 Khairkhahan Jul 2007 A1
20070185513 Woolfson et al. Aug 2007 A1
20070203391 Bloom et al. Aug 2007 A1
20070203503 Salahieh et al. Aug 2007 A1
20070225681 House Sep 2007 A1
20070232898 Huynh et al. Oct 2007 A1
20070233228 Eberhardt et al. Oct 2007 A1
20070233237 Krivoruchko Oct 2007 A1
20070233238 Huynh et al. Oct 2007 A1
20070237802 McKay Oct 2007 A1
20070238979 Huynh et al. Oct 2007 A1
20070239254 Chia et al. Oct 2007 A1
20070239265 Birdsall Oct 2007 A1
20070239266 Birdsall Oct 2007 A1
20070239269 Dolan et al. Oct 2007 A1
20070239271 Nguyen Oct 2007 A1
20070239273 Allen Oct 2007 A1
20070244544 Birdsall et al. Oct 2007 A1
20070244545 Birdsall et al. Oct 2007 A1
20070244546 Francis Oct 2007 A1
20070244553 Rafiee et al. Oct 2007 A1
20070244554 Rafiee et al. Oct 2007 A1
20070244555 Rafiee et al. Oct 2007 A1
20070244556 Rafiee et al. Oct 2007 A1
20070244557 Rafiee et al. Oct 2007 A1
20070250160 Rafiee Oct 2007 A1
20070255394 Ryan Nov 2007 A1
20070255396 Douk et al. Nov 2007 A1
20070260305 Drews et al. Nov 2007 A1
20070265701 Gurskis et al. Nov 2007 A1
20070270944 Bergheim et al. Nov 2007 A1
20070288000 Bonan Dec 2007 A1
20070293942 Mirzaee Dec 2007 A1
20080004696 Vesely Jan 2008 A1
20080009940 Cribier Jan 2008 A1
20080015671 Bonhoeffer Jan 2008 A1
20080021552 Gabbay Jan 2008 A1
20080048656 Tan et al. Feb 2008 A1
20080065204 Macoviak et al. Mar 2008 A1
20080065206 Liddicoat Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080077234 Styrc Mar 2008 A1
20080082164 Friedman Apr 2008 A1
20080082165 Wilson et al. Apr 2008 A1
20080082166 Styrc et al. Apr 2008 A1
20080097595 Gabbay Apr 2008 A1
20080103586 Styrc et al. May 2008 A1
20080125859 Salahieh et al. May 2008 A1
20080133033 Wolff et al. Jun 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080147105 Wilson et al. Jun 2008 A1
20080147160 Ghione et al. Jun 2008 A1
20080147180 Ghione et al. Jun 2008 A1
20080147181 Ghione et al. Jun 2008 A1
20080147182 Righini et al. Jun 2008 A1
20080154355 Benichou et al. Jun 2008 A1
20080154356 Obermiller et al. Jun 2008 A1
20080161910 Revuelta et al. Jul 2008 A1
20080161911 Revuelta et al. Jul 2008 A1
20080183273 Mesana et al. Jul 2008 A1
20080188880 Fischer et al. Aug 2008 A1
20080188928 Salahieh et al. Aug 2008 A1
20080215143 Seguin Sep 2008 A1
20080215144 Ryan et al. Sep 2008 A1
20080228254 Ryan Sep 2008 A1
20080228263 Ryan Sep 2008 A1
20080234797 Styrc Sep 2008 A1
20080243246 Ryan et al. Oct 2008 A1
20080249619 Stacchino et al. Oct 2008 A1
20080255651 Dwork Oct 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080255661 Straubinger et al. Oct 2008 A1
20080255662 Stacchino et al. Oct 2008 A1
20080262593 Ryan et al. Oct 2008 A1
20080269878 Iobbi Oct 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090012600 Styrc et al. Jan 2009 A1
20090018570 Righini et al. Jan 2009 A1
20090048656 Wen Feb 2009 A1
20090054976 Tuval et al. Feb 2009 A1
20090069886 Suri et al. Mar 2009 A1
20090069887 Righini et al. Mar 2009 A1
20090069889 Suri et al. Mar 2009 A1
20090082858 Nugent et al. Mar 2009 A1
20090099653 Suri et al. Apr 2009 A1
20090138079 Tuval et al. May 2009 A1
20090157175 Benichou Jun 2009 A1
20090164004 Cohn Jun 2009 A1
20090164006 Seguin et al. Jun 2009 A1
20090171447 Von Segesser et al. Jul 2009 A1
20090171456 Kveen et al. Jul 2009 A1
20090192585 Bloom et al. Jul 2009 A1
20090192586 Tabor et al. Jul 2009 A1
20090192591 Ryan et al. Jul 2009 A1
20090198316 Laske et al. Aug 2009 A1
20090209955 Forster et al. Aug 2009 A1
20090210052 Forster et al. Aug 2009 A1
20090216310 Straubinger et al. Aug 2009 A1
20090216312 Straubinger et al. Aug 2009 A1
20090216313 Straubinger et al. Aug 2009 A1
20090222082 Lock et al. Sep 2009 A1
20090222084 Friedman Sep 2009 A1
20090234443 Ottma et al. Sep 2009 A1
20090240264 Tuval et al. Sep 2009 A1
20090240320 Tuval et al. Sep 2009 A1
20090254165 Tabor et al. Oct 2009 A1
20090287299 Tabor et al. Nov 2009 A1
20100004740 Seguin et al. Jan 2010 A1
20100030328 Seguin et al. Feb 2010 A1
20100036479 Hill et al. Feb 2010 A1
20100036485 Seguin Feb 2010 A1
20100069852 Kelley Mar 2010 A1
20100094411 Tuval et al. Apr 2010 A1
20100100167 Bortlein et al. Apr 2010 A1
20100131054 Tuval et al. May 2010 A1
20100137979 Tuval et al. Jun 2010 A1
20100145439 Seguin et al. Jun 2010 A1
20100152840 Seguin et al. Jun 2010 A1
20100161045 Righini Jun 2010 A1
20100198346 Keogh et al. Aug 2010 A1
20100234940 Dolan Sep 2010 A1
20100256723 Murray Oct 2010 A1
20100274351 Rolando et al. Oct 2010 A1
20100292782 Giannetti et al. Nov 2010 A1
20110082539 Suri Apr 2011 A1
20110288636 Rolando et al. Nov 2011 A1
20120172982 Stacchino et al. Jul 2012 A1
20130325112 Stacchino et al. Dec 2013 A1
20130345800 Stacchino et al. Dec 2013 A1
20140052243 Rolando et al. Feb 2014 A1
20140052244 Rolando et al. Feb 2014 A1
Foreign Referenced Citations (107)
Number Date Country
101011298 Aug 2007 CN
3640745 Jun 1987 DE
19532846 Mar 1997 DE
19907646 Aug 2000 DE
10010074 Oct 2001 DE
10049812 Apr 2002 DE
10049813 Apr 2002 DE
10049815 Apr 2002 DE
10121210 Nov 2002 DE
19546692 Nov 2002 DE
10301026 Feb 2004 DE
19857887 May 2005 DE
0133420 Feb 1988 EP
0155245 May 1990 EP
0592410 Oct 1995 EP
0515324 Dec 1996 EP
0850607 Jul 1998 EP
1057460 Dec 2000 EP
1259194 Feb 2005 EP
1214020 Mar 2005 EP
2055266 May 2005 EP
1088529 Jun 2005 EP
1570809 Sep 2005 EP
1014896 Nov 2005 EP
1469797 Nov 2005 EP
1603493 Dec 2005 EP
1603493 Dec 2005 EP
1600127 Nov 2006 EP
1255510 Apr 2007 EP
1143882 May 2007 EP
1143882 Dec 2007 EP
1913901 Apr 2008 EP
1690515 Jul 2008 EP
1330213 Mar 2009 EP
2047824 Apr 2009 EP
2055266 May 2009 EP
1370201 Sep 2009 EP
2119417 Nov 2009 EP
2133039 Dec 2009 EP
2133039 Dec 2009 EP
2788217 Jul 2000 FR
2815844 Jan 2003 FR
2056023 Aug 1983 GB
2433700 Jul 2007 GB
1017275 Aug 2002 NL
1271508 Nov 1986 SU
WO9209247 Jun 1992 WO
WO9529640 Nov 1995 WO
WO 9724989 Jul 1997 WO
WO 9817202 Apr 1998 WO
WO 9829057 Jul 1998 WO
WO 9913802 Mar 1999 WO
WO 9956665 Nov 1999 WO
WO 0041652 Jul 2000 WO
WO 0047139 Aug 2000 WO
WO0044313 Aug 2000 WO
WO0047136 Aug 2000 WO
WO 0062714 Oct 2000 WO
WO 0062716 Oct 2000 WO
WO 0121107 Mar 2001 WO
WO0135870 May 2001 WO
WO0149213 Jul 2001 WO
WO 0162189 Aug 2001 WO
WO0154625 Aug 2001 WO
WO 0164137 Sep 2001 WO
WO 0176510 Oct 2001 WO
WO0222054 Mar 2002 WO
WO0236048 May 2002 WO
WO 02041789 Aug 2002 WO
WO 02076348 Oct 2002 WO
WO 02047575 Dec 2002 WO
WO03003943 Jan 2003 WO
WO03011195 Feb 2003 WO
WO03047468 Jun 2003 WO
WO 03003943 Nov 2003 WO
WO 03094797 Nov 2003 WO
WO2004019825 Mar 2004 WO
WO 2004082527 Sep 2004 WO
WO2004089250 Oct 2004 WO
WO2005004753 Jan 2005 WO
WO 2004091455 Feb 2005 WO
WO 2005046528 May 2005 WO
WO2005062980 Jul 2005 WO
WO2006026371 Mar 2006 WO
WO 2006044679 Apr 2006 WO
WO2006086135 Aug 2006 WO
WO2006086135 Aug 2006 WO
WO2006124649 Nov 2006 WO
WO2006127765 Nov 2006 WO
WO2006135831 Dec 2006 WO
WO2007009117 Jan 2007 WO
WO2007071436 Jun 2007 WO
WO2007130537 Nov 2007 WO
WO2008047354 Apr 2008 WO
WO2008070797 Jun 2008 WO
WO2008138584 Nov 2008 WO
WO2008150529 Dec 2008 WO
WO2009002548 Dec 2008 WO
WO2009024716 Feb 2009 WO
WO 2009029199 Mar 2009 WO
WO2009042196 Apr 2009 WO
WO2009045331 Apr 2009 WO
WO2009045338 Apr 2009 WO
WO2009061389 May 2009 WO
WO2009091509 Jul 2009 WO
WO2009094188 Jul 2009 WO
WO2009111241 Sep 2009 WO
Non-Patent Literature Citations (55)
Entry
European Search Report issued in EP Publication No. 1507809, dated Jan. 5, 2007, 5 pages.
International Search Report issued in International Application No. PCT/IB2006/000967, published as WO2006/085225, mailed Jul. 6, 2006.
European Search Report issued in EP App No. 09158822, dated Sep. 29, 2009, 5 pages.
Andersen, H.R. et al, “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” Euro. Heart J. (1992) 13:704-708.
Babaliaros, et al., “State of the Art Percutaneous Intervention for the Treatment of Valvular Heart Disease: A Review of the Current Technologies and Ongoing Research in the Field of Percutaneous Heart Valve Replacement and Repair,” Cardiology 2007; 107:87-96.
Bailey, “Percutaneous Expandable Prosthetic Valves,” In: Topol EJ, ed. Textbook of Interventional Cardiology. vol. II. Second edition. WB Saunders, Philadelphia, 1994:1268-1276.
Block, et al., “Percutaneous Approaches to Valvular Heart Disease,” Current Cardiology Reports, vol. 7 (2005) pp. 108-113.
Bonhoeffer, et al, “Percutaneous Insertion of the Pulmonary Valve,” Journal of the American College of Cardiology (United States), May 15, 2002, pp. I 664-I 669.
Bonhoeffer, et al, “Percutaneous Replacement of Pulmonary Valve in a Right-Ventricle to Pulmonary-Artery Prosthetic Conduit with Valve Dysfunction,” Lancet (England), Oct. 21, 2000, pp. 1403-1405.
Bonhoeffer, et al, “Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study,” Circulation (United States), Aug. 15, 2000, pp. 813-816.
Boudjemline, et al, “Images in Cardiovascular Medicine. Percutaneous Aortic Valve Replacement in Animals,” Circulation (United States), Mar. 16, 2004.
Boudjemline, et al, “Is Percutaneous Implantation of a Bovine Venous Valve in the Inferior Vena Cava a Reliable Technique to Treat Chronic Venous Insufficiency Syndrome?” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research (Poland), Mar. 2004, pp. BR61-BR66.
Boudjemline, et al, “Off-pump Replacement of the Pulmonary Valve in Large Right Ventricular Outflow Tracts: A Hybrid Approach,” Journal of Thoracic and Cardiovascular Surgery (United States), Apr. 2005, pp. 831-837.
Boudjemline, et al, “Percutaneous Aortic Valve Replacement: Will We Get There?” Heart (British Cardiac Society) (England), Dec. 2001, pp. 705-706.
Boudjemline, et al, “Percutaneous Implantation of a Biological Valve in Aortic Position: Preliminary Results in a Sheep Study,” European Heart Journal 22, Sep. 2001, p. 630.
Boudjemline, et al, “Percutaneous Implantation of a Biological Valve in the Aorta to Treat Aortic Valve Insufficiency—A Sheep Study,” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research (Poland), Apr. 2002, pp. BR113-BR116.
Boudjemline, et al, “Percutaneous Implantation of a Valve in the Descending Aorta in Lambs,” European Heart Journal (England), Jul. 2002, pp. 1045-1049.
Boudjemline, et al, “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract: An Experimental Study,” Journal of the American College of Cardiology (United States), Mar. 17, 2004, pp. 1082-1087.
Boudjemline, et al, “Percutaneous Valve Insertion: A New Approach,” Journal of Thoracic and Cardiovascular Surgery (United States), Mar. 2003, pp. 741-742.
Boudjemline, et al, “Stent Implantation Combined with a Valve Replacement to Treat Degenerated Right Ventricle to Pulmonary Artery Prosthetic Conduits,” European Heart Journal 22, Sep. 2001, p. 355.
Boudjemline, et al, “Steps Toward Percutaneous Aortic Valve Replacement,” Circulation (United States), Feb. 12, 2002, pp. 775-778.
Boudjemline, et al, “The Percutaneous Implantable Heart Valve,” Progress in Pediatric Cardiology (Ireland), 2001, pp. 89-93.
Boudjemline, et al, “Transcatheter Reconstruction of the Right Heart,” Cardiology in the Young (England), Jun. 2003, pp. 308-311.
Coats, et al, “The Potential Impact of Percutaneous Pulmonary Valve Stent Implantation on Right Ventricular Outflow Tract Re-Intervention,” European Journal of Cardio-Thoracic Surgery (England), Apr. 2005, pp. 536-543.
Cribier, A. et al, “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description,” Circulation (2002) 3006-3008.
Davidson et al., “Percutaneous therapies for valvular heart disease,” Cardiovascular Pathology 15 (2006) 123-129.
European Search Report issued in EP 10183557, mailed Apr. 11, 2011, 7 pages.
European Search Report issued in EP App No. 08165227, dated Mar. 13, 2009.
European Search Report issued in EP Application No. 05004289, dated Jun. 2, 2005, 3 pages.
European Search Report issued in EP Application No. 06101425, dated May 3, 2006, 6 pages.
European Search Report issued in EP Application No. 08150075, dated Mar. 27, 2008, 6 pages.
Extended European Search Report issued in EP 09179414, dated Oct. 18, 2010, 8 pages.
Hanzel, et al., “Complications of percutaneous aortic valve replacement: experience with the CriberEdwardsTm percutaneous heart valve,” Eurointervention Supplements (2006), I (Supplement A) A3-A8.
Huber, et al., “Do Valved Stents Compromise Coronary Flow?” Eur. J. Cardiothorac. Surg. 2004;25:754-759.
Khambadkone, “Nonsurgical Pulmonary Valve Replacement: Why, When, and How?” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiography & Interventions (United States), Jul. 2004, pp. 401-408.
Khambadkone, et al, “Percutaneous Implantation of Pulmonary Valves,” Expert Review of Cardiovascular Therapy (England), Nov. 2003, pp. 541-548.
Khambadkone, et al, “Percutaneous Pulmonary Valve Implantation: Early and Medium Term Results,” Circulation 108 (17 Supplement), Oct. 28, 2003, p. 1V-375.
Khambadkone, et al, “Percutaneous Pulmonary Valve Implantation: Impact of Morphology on Case Selection,” Circulation 108 (17 Supplement), Oct. 28, 2003, p. IV-642-IV-643.
Lutter, et al, “Percutaneous Aortic Valve Replacement: An Experimental Study. I. Studies on Implantation,” The Journal of Thoracic and Cardiovascular Surgery, Apr. 2002, pp. 768-776.
Lutter, et al, “Percutaneous Valve Replacement: Current State and Future Prospects,” Annals of Thoracic Surgery (Netherlands), Dec. 2004, pp. 2199-2206.
Ma, Ling, et al., “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio Thoracic Surgery, 28:194-198, 2005.
Medtech Insight, “New Frontiers in Heart Valve Disease,” vol. 7, No. 8 (2005).
Palacios, “Percutaneous Valve Replacement and Repair, Fiction or Reality?” Journal of American College of Cardiology, vol. 44, No. 8 (2004) pp. 1662-1663.
Pavcnik et al., “Aortic and venous valve for percutaneous insertion,” Min. Invas. Ther. & Allied Techol. 2000, vol. 9, pas. 287-292.
Pelton et al., “Medical Uses of Nitinol,” Materials Science Forum vol. 327-328, pp. 63-70 (2000).
Ruiz, “Transcathether Aortic Valve Implantation and Mitral Valve Repair: State of the Art,” Pediatric Cardiology, vol. 26, No. 3 (2005).
Saliba, et al, “Treatment of Obstructions of Prosthetic Conduits by Percutaneous Implantation of Stents,” Archives des Maldies du Coeur et des Vaisseaux (France), 1999, pp. 591-596.
Stassano et al., “Mid-term results of the valve-on-valve technique for bioprosthetic failure,” Eur. J. Cardiothorac. Surg. 2000; 18:453-457.
Webb, et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery,” Circulation (2006), 1 13;842-850.
European Search Report issued in EP Application No. 11425029, dated Aug. 17, 2011, 5 pages.
European Search Report issued in EP Application No. 11425030, dated Aug. 10, 2011, 5 pages.
International Search Report and Written Opinion issued in PCT/IB2012/050604, mailed Jul. 26, 2012, 16 pages.
International Search Report and Written Opinion issued in PCT/IB2012/050608, mailed Jul. 24, 2012, 9 pages.
Roth, Mark, “Old metal heart valve did its job for 42 years”, Pittsburgh Post-Gazette, Wednesday Mar. 5, 2008, 3 pages.
Grube, Eberhard et al., Case Report entitled “First Report on a Human Percutaneous Transluminal Implantation of a Self-Expanding Valve Prosthesis for Interventional Treatment of Aortic Valve Stenosis”, Valvular Heart Disease, Catheterization and Cardiovascular Interventions, 2005, 66:465-469.
Related Publications (1)
Number Date Country
20090287296 A1 Nov 2009 US
Provisional Applications (1)
Number Date Country
61053943 May 2008 US